Uncategorized

Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001

by Business Wire • 2022/06/24 • 0 Comments

BASEL, Switzerland--(BUSINESS WIRE)--Kinarus will host a key opinion leader (KOL) event for investors in Zurich on Monday, June 27, starting at 12:15 pm CET.

Full Story →

← Patients with Uveal Melanoma Tested with DecisionDx®-UM Report Gaining Value from Test Results In Study Conducted In Collaboration with the Melanoma Research Foundation’s CURE OM Initiative

Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States →

Post navigation